Paper Details

  1. Home
  2. Paper Details

[An Undeniable Case of Optic Neuropathy Due to Cabazitaxel].

Author: KanekoMasatomo, KawaraHiroko, KawashimaYugo, NakauchiHiroo, NoguchiYusuke, TokuyamaYoko

English AbstractA summary of a research paper/publication written in English for a wider audience.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a 78-year-old man who developed optic neuropathy during cabazitaxel treatment for prostate cancer. This is the first report of optic neuropathy associated with cabazitaxel. This case highlights the need for careful monitoring for eye disorders during taxane-type antineoplastic agent administration.
Paper Details　
Original Abstract of the Article :
Cabazitaxelis a taxane-type antineoplastic agent used for treating prostate cancer. Although typical side effects include neutropenia and fatigue, no studies have investigated eye disorders as a possible side effect, and the details are not clear. Herein, we report our experience of an undeniable ca...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/27306820

データ提供：米国国立医学図書館（NLM）

A Case of Optic Neuropathy Associated with Cabazitaxel: A Case Report

The field of oncology constantly seeks to improve cancer treatments. However, the journey to find effective therapies often involves careful monitoring of potential side effects. This case report investigates a rare case of optic neuropathy associated with cabazitaxel, a taxane-type antineoplastic agent used to treat prostate cancer.

The patient, a 78-year-old man with stage IV prostate cancer, developed optic neuropathy during cabazitaxel treatment. The patient experienced a decline in vision, narrowing of the field of vision, and impaired color vision. This case report underscores the potential for optic neuropathy to occur as a side effect of cabazitaxel, a previously underreported complication.

Navigating the Landscape of Drug Side Effects

This case report highlights the importance of ongoing vigilance and careful monitoring for potential side effects, even with established treatments.

A Camel's Perspective on Cancer Treatment

As a camel, I’ve seen the resilience of life in the desert, even in the face of adversity. This case report reminds us that even with the most promising treatments, we must be aware of potential side effects.

Dr.Camel's Conclusion

This case report presents a compelling case for optic neuropathy as a potential side effect of cabazitaxel treatment for prostate cancer. The findings underscore the need for continued vigilance and careful monitoring for this potential complication.

Date :
  1. Date Completed 2016-08-05
  2. Date Revised 2016-06-16
Further Info :

Pubmed ID

27306820

DOI: Digital Object Identifier

27306820

Related Literature

Article Analysis
・Side Effects of bicalutamide
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.